Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside

Why did Tesla's stock soar after robotaxi launch? How will US-Iran conflict impact oil prices? What caused Kroger to announce store closures? Why are Fed officials signaling potential rate cuts? How is the Iran strike affecting global markets? What’s behind Compass suing Zillow over listings? Why is Fiserv entering the stablecoin market?

Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside

benzinga.com/analyst-stock-ratings/initiation/25/06/46060153/analyst-flags-septerna-as-undervalued-biotech-play-with-significant-upside

On Monday, HC Wainwright initiated coverage on Septerna, Inc. (NASDAQ:SEPN), citing a next-generation drug design platform aimed at hitherto-undruggable targets.
Septerna is working on G protein-coupled receptor (GPCR) drug discovery powered by its proprietary Native Complex Platform. Its…

This story appeared on benzinga.com, 2025-06-23 18:30:53.